In Brief Teng et al. show that exosome-like nanoparticles (ELNs) from edible plants such as ginger are preferentially taken up by gut bacteria in an ELN lipid-dependent manner. ELN RNAs regulate gut microbiota composition and localization as well as host physiology, notably enhancing gut barrier function to alleviate colitis.
INTRODUCTION
Diet has been demonstrated to have a considerable effect on the composition of the gut microbiota throughout the human lifespan (Sonnenburg et al., 2016) . Different human populations can have vastly different intestinal microbiomes, and changes in diet lead to changes in microbiota composition (Maslowski and Mackay, 2011) . Owing to the essential role of the gut microbiota in maintaining host physiology, its alteration as a result of an unhealthy diet can trigger a wide range of physiological disorders, including metabolic disorders (Chassaing and Gewirtz, 2014) . Vegetables are mostly made of cells that contain high levels of nucleic acids, including RNA (Garcia-Segura et al., 2013) . Although it is known that food, including edible plants, are the main carbon and energy source for gut microbes, whether the expression of gut bacterial genes is affected by edible plant RNA is not known. A number of diet-derived metabolites promote activation of the aryl hydrocarbon receptor (AHR)-mediated pathway (Bessede et al., 2014; Li et al., 2011) . Activation of the AHR pathway results in induction of IL-22 (Monteleone et al., 2011) . IL-22 prevents systemic dissemination of intestinal microbiota (Sonnenberg and Artis, 2012) . However, it is not known whether edible plant-derived exosome-like nanoparticle (ELN) RNA has a role in induction of IL-22 via activation of AHR.
Our published data indicate that ELN-host cell interactions can prevent alcohol-induced liver damage (Zhuang et al., 2015) and dextran sulfate sodium (DSS)-induced colitis in mouse models . Those initial findings encouraged us to further determine (1) whether ELNs can be taken up by gut bacteria and (2) upon taking up the ELNs, whether the dietderived ELN RNA affects the biology of gut bacteria.
Here, we show that ELNs, such as ginger ELNs (GELNs), are preferentially taken up by gut bacteria, resulting in changes in the composition and localization of bacteria, as well as in host physiology. Phosphatidic acid (PA)-enriched GELNs send a signal to Lactobacillus rhamnosus (LGG), resulting in preferential uptake of GELNs. Once GELNs are taken up by LGG, GELNRNAs interact with a panel of LGG genes, altering the composition of the gut microbiota. Meanwhile, metabolites released from GELN-RNA-treated LGG in turn regulate the growth of other gut bacteria. Collectively and as proof of concept, these findings indicate a mechanism that underlies selective uptake of GELNs by LGG and opens up avenues for studying molecular pathway(s) that underlie how diet through ELNs regulate cross-talk between gut microbiota and host cells.
RESULTS

GELN-RNA Shapes Gut Microbiota
A number of edible nanoparticles have been characterized based on electron microscopy (EM) examination (Mu et al., 2014) . In this study, in addition to EM imaging ( Figure S1A ), GELNs were characterized based on size distribution (Figure S1B) and the RNAs ( Figure S1C ) and proteins ( Figure S1D ) present. Gel electrophoresis demonstrated the presence of substantial amounts of small-sized RNAs (less than 300 nucleotides). The yield and number of GELNs per gram of ginger tissue and yield of GELN-RNA per milligram of GELNs were also quantitatively analyzed ( Figure S1E ). The purity of GELN preparations was determined by comparing the ratio of GELN counts to protein concentration ( Figure S1F ). Next-generation sequencing analysis of GELN-RNA (Table S1 ) further suggested that GELNs contained miRNAs. At a sequencing depth of 20 million reads, 93,679 of the miRNA reads were mapped to 109 mature miRNAs from the NCBI plant miRNA database (Table S1 ). A number of bacterial mRNAs that could be potentially bound by a seed sequence (7-8 NTs) of GELN miRNAs are listed in Figure S1G .
It is obvious that ELN RNA stability in the gut is required for potential interaction of ELN RNA with gut bacterial mRNA. Analysis of the tissue distribution of ELNs indicated that grapefruit ELNs preferentially migrated to the liver, but GELNs were more likely to stay in the intestine ( Figure S2A ). The evidence of GELNs in the gut and feces over a 6-hr period was further confirmed by quantitative PCR (qPCR) analysis of GELN miRNA alymiR319a-3p and grapefruit miRNA vvi-miR166c ( Figure S2B ). The PCR results ( Figure S2C ) indicate that in fewer than 30 PCR cycles, only aly-miR319a was detected in the feces of mice fed GELNs, whereas vvi-miR166c was only detected in the feces of mice fed with grapefruit ELNs, suggesting that qPCR analysis of fecal samples provides a specific and sensitive approach to investigating the stability of ELNs in the gut.
The above findings led us to investigate whether GELNs cross talk with gut microbiota and regulate their composition. We collected fecal samples from C57BL/6 mice that were administered GELNs for a week and then analyzed the microbial composition via 16S rRNA gene (v1-v3 regions) sequencing (the sequencing data were deposited in NCBI Sequence Read Archive [SRA] , accession number SRA: SRP121341). Further downstream analysis was performed using QIIME 1.9.1 pipeline tools (Caporaso et al., 2010) . Microbial alignment and classification was performed using the Green Genes reference database (gg_13_8_otus) as described in the Star Methods. We found an increase in Lactobacillaceae and Bacteroidales S24-7 and a decrease in Clostridiaceae in GELN-treated mice in comparison with mice treated with PBS ( Figure 1A , Table S2 ). The Lactobacillaceae percentage increased from 0.25% ± 0.15% to 24.80% ± 5.41% (p < 0.001) in mice that received GELNs by gavage. The sequencing data were subsequently verified using a qPCR assay ( Figure 1B ). We next estimated the effect of GELNs at a high dose of 10 mg/25 g of body weight and at a low dose of 0.5 mg/25 g of body weight (a physiologically relevant dose for human intake; Schwertner et al., 2006) on the composition of gut bacteria. The results generated from both higher and lower doses of GELNs supported the conclusion that GELN treatment increases Lactobacillaceae and Bacteroidaceae and decreases Clostridiaceae compared with PBS ( Figure S2D ). Neither the higher nor lower doses of GELNs induced any abnormalities in treated mice compared with PBS control mice, based on serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ( Figure S2E ). We next investigated whether the impact of GELNs on gut microbiota composition is associated with sex. Gene sequencing analysis of 16S rRNA indicated that although the percentage of the abundance of the bacteria analyzed were variable between male and female mice in response to GELNs, the overall trend affecting the increase or decrease in bacteria is the same regardless of sex. Notably, GELNs induce Lactobacillaceae and Bacteroidaceae and decrease Clostridiaceae in both males and females to varying degrees ( Figure S3A , Table S2 ).
To address whether ELN RNAs influence gut microbiota composition, ELN RNAs from ginger, grapefruit, and carrot were extracted from purified ELNs and encapsulated in GELN nanovectors (GNVs) made with GELN-derived lipid. The results indicated that the mice gavaged with ginger, grapefruit, or carrot ELN RNAs exhibited a change in the composition of gut microbiota ( Figure 1C ), which would suggest that edible plant ELN RNAs have an effect on the gut microbiota composition in Figure 1 . GELNs Shape Gut Microbiota and Uptake by Gut Bacteria (A) GELNs or PBS were fed to C57BL/6 mice every other day for a total of three times. Bacterial DNA from feces was evaluated using 16S rRNA gene sequencing (n = 5). The bar graph shows the percentage of each bacteria sequence in all sequence reads at the level of family. (B) Selected bacteria identified by qPCR in feces of mice. Sequencing results (left); qPCR results (right); GELNs versus PBS, *p < 0.05. (C) Heatmap depicting the mouse gut microbiota using a qPCR array; red and blue represent high and low levels of bacteria, respectively. (D) Healthy subjects treated with GELNs (n = 28) or 0.9% NaCl (n = 30). Bacteria in feces were evaluated via 16S rRNA gene sequencing after being randomly pooled into three groups. The bar graph shows the percentage of each bacteria sequence in all sequence reads (bottom left). The level of selected bacteria verified with qPCR (bottom right). GELNs versus 0.9% NaCl, *p < 0.05. (E) A representative confocal microscopy image of a fecal sample from mice fed PKH26-labeled GELNs (left; scale bar, 10 mm) and quantitative FACS analysis (right). (F) Schematic representation of the treatment schedule for PKH2-labeled GELN uptake by gut bacteria in mice (n = 5 mice per group). (G) The bar graph shows the results of 16S rRNA sequencing at the level of family for bacteria with a preference for taking up GELNs. The data are representative of three independent experiments (error bars, SD). See also Figures S1 and S2 and Tables S2 and S3. Cell Host & Microbe 24, 1-16, November 14, 2018 3 general. Ginger ELN RNAs induced several species of Lactobacillus identical to GELNs when compared with GNVs as a control. However, carrot ELN RNAs seemed to have no effect on the Lactobacillus level. Cluster analysis using R software (Rosselli et al., 2016) indicated that PBS and GNVs are grouped in the same cluster ( Figure 1C ), GNVs/grapefruit ELN RNAs and GNVs/carrot ELN RNAs are in the same cluster, and GNVs/ GELN-RNAs have the least similarity with the other two clusters.
To further determine whether our findings described above can be translated into clinical application, 16S rRNA gene sequencing data generated from stool samples of healthy subjects after oral GELN administration for a week were quantitatively analyzed ( Figure 1D , top panel). To exclude the bias of sex in the study results, bacterial DNA from both males and females in each treatment group was pooled into three groups prior to 16S rRNA sequencing. The percentage of each bacterial species sequence in all sequence reads indicated an increase in Lactobacillaceae, Bacteroidaceae and Bacteroidales S24-7 and a decrease in Clostridiaceae and Ruminococcaceae in GELNtreated subjects in comparison with particle vehicle (0.9% NaCl)-treated subjects ( Figure 1D , bottom left panel; Table S2 ). The sequencing data from healthy subjects were subsequently verified with a qPCR assay ( Figure 1D , bottom right panel).
Considering the direct contact of food ELNs and numerous bacteria in the gut, we hypothesized that food ELNs might be taken up by bacteria, and the contents of food ELN RNAs could directly regulate gene expression in bacteria. To test our hypothesis, PKH26-labeled GELNs were administered to C57BL/6 mice via oral gavage. Confocal imaging analysis indicated that the GELNs were taken up by gut bacteria ( Figure 1E , left panel), and this result was further confirmed by quantitative fluorescence-activated cell sorting (FACS) analysis of PKH26 + GELNs ( Figure 1E , right panel).
To determine whether the changes in gut bacteria composition were associated with preferential uptake of GELNs by specific gut microbiota, PKH26 + GELNs were administered to mice via oral gavage. The PKH26 + bacteria from fecal samples of mice were sorted by FACS ( Figure 1F ) followed by 16S rRNA gene sequencing. The results showed that 31.54% (±7.92%) of the GELNs/PKH26-positive gut bacteria were Lactobacillaceae (Figure 1G, Table S3 ). Next, we determined whether the concept that edible plant exosomes can preferentially target bacteria in the intestine can be generalized. ELNs from turmeric, which belongs to the same family as ginger, garlic, and grapefruit, were used as proof of concept. We generated a 16S ribosomal rRNA gene library and applied 16S sequencing analysis of fecal samples from mice administered PKH26 + ELNs from garlic, turmeric, and grapefruit ( Figure S3B , Table S3 ). The analysis of GELN + bacteria suggested that all three types of ELNs were preferentially taken up by Bacteroidales S24-7. Interestingly, turmeric, from the same Zingiberaceae family as ginger, was also preferentially taken up by Lactobacillaceae. In contrast, garlic-and grapefruit-derived ELNs were preferentially taken up by Ruminococcaceae. These data established a foundation for further study of the molecular basis underlying preferential uptake by gut microbiota.
Our data show that Lactobacillaceae numbers increased in GELN-administered mice ( Figure 1A ) and that GELNs were preferentially taken up by Lactobacillaceae ( Figure 1G ). The results generated from in vitro cultures of LGG with GELNs indicated that GELNs directly promoted LGG growth ( Figures S4A-S4D ), whereas grapefruit-derived ELNs reduced LGG growth (Figure S4D ). To determine whether GELNs also have an effect on the growth of other Lactobacillus species and other families of bacteria, the growth of Lactobacillus reuteri (L. reuteri), Lactobacillus murinus (L. murinus), Bacillus fragilis, Escherichia coli, and Ruminococcaceae sp. (TSD-27) was evaluated after incubation with GELNs for 8 hr. We found that GELNs also induced L. reuteri and L. murinus growth ( Figure S4E ). GELNs had no effect on B. fragilis or E. coli growth, but we observed that GELNs inhibited Ruminococcaceae growth ( Figure S4E ). It is known that the metabolites released from one species of gut bacteria can have an effect on the growth of other species. Our data show that the metabolic products from GELN-treated LGG inhibited Listeria, E. coli, and B. fragilis growth in vitro (Figures S4F and S4G) and in vivo ( Figures S4F and S4H ) but had no effect on LGG growth. Collectively, these data suggest that GELNs can regulate LGG metabolites and prompted us to select LGG for further analysis of the molecular mechanisms underlying GELN-mediated biological effects on LGG.
GELNs Are Selectively Taken Up by Gut Bacteria and Regulate the Expression of LGG mRNA and Protein To explore the mechanism by which ELNs are preferentially taken up by specific bacteria, we next assessed comparative lipid profiles generated from mass spectrometry (MS) analysis (Table S4) . We found that GELN and turmeric ELN-derived lipids were enriched with PAs (35.2% and 34.4%, respectively), primarily 1,2-dilinoleoyl-sn-glycero-3-phosphate, C18:1/C18:3 (36:4) and 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphate, C16:0/C18:2 (34:2), whereas PAs in grapefruit and garlic represented only 3.5% and 5.5%, respectively, of the total lipid content ( Figure 2A ). In contrast, the majority of the lipid in grapefruit and garlic was phosphatidylcholine (PC, 36.2% and 52.6%, respectively). We hypothesized that GELN PA lipids may serve as a signal for preferential uptake by LGG. To generate PA-depleted GELN lipids, GELN lipids were isolated with chloroform and separated via thin-layer chromatography (TLC) ( Figure 2B ). The band containing PA was identified based on standard PA migration in TLC and then removed. The results generated from GNVs made from PA-depleted GELN lipids ( Figure 2C ) indicated that depletion of GELN PA lipids leads to a significant reduction in GNV-positive LGG, whereas addition of PA 34:2 or PA 36:4 back into PA-depleted GNVs rescued the uptake of GNVs, and grapefruit ELN lipid-derived nanovector (GFNV) uptake by LGG was minimal ( Figure 2C ). These data suggest that PA is required for GELN uptake by LGG. ELN lipid-dependent uptake was also demonstrated in grapefruit ELNs. FACS analysis indicated that PC-enriched grapefruit GFNVs were preferentially taken up by Ruminococcaceae (TSD-27). PC depletion in grapefruit GFNVs resulted in reduced uptake by Ruminococcaceae, and the uptake was rescued by addition of PC 34:2 back into the PC-depleted grapefruit GNVs ( Figure 2D ). To further determine whether lipids also play a role in tissue targeting in vivo, mice were gavaged with DiR-labeled GELNs, PA-depleted GELNs, GELNs plus PC 34:2, grapefruit ELNs, and PC-depleted grapefruit ELNs. Analysis of imaging signals in mouse intestines and livers was performed at 1 hr and 6 hr after the gavage. The results suggest that PA lipids play a role in maintaining the duration and amount of ELN accumulation in the gut. PC lipid enhances migration of ELNs from the intestine to the liver ( Figure 2E ).
To determine whether GELNs have an effect on gene expression and protein production in LGG, we first sought to determine the efficiency of PKH26-labeled GELN uptake by LGG in an in vitro culture assay.
LGG was incubated with PKH26-labeled GELNs for 1 hr at 22 C, and uptake of GELNs by LGG was visualized with confocal microscopy. We then evaluated GELN uptake in vivo. Briefly, 2 hr after mice were gavaged with PKH67 fluorescencelabeled LGG (1 3 10 9 ), the mice were administered PKH26-labeled GELNs (500 mg/kg of body weight in 300 mL of PBS). Twelve hr after the last gavage, analysis of the PKH67 + PKH26 + double-positive bacteria suggested that LGG took up the GELNs. In vitro confocal ( Figure 2F ) and in vivo FACS analysis ( Figure 2G ) data suggested that LGG took up the GELNs. We then obtained an LGG gene expression profile using next-generation mRNA sequencing ( Figures 2H and 2I 
PKH26
+ LGG. The RNA sequencing ( Figure 2I ) and proteomic ( Figure 2K ) data analyses indicated that 398 mRNAs and 149 proteins were predominantly present in GELN-treated LGG. In addition, 249 LGG mRNAs and 133 proteins were reduced in GELN-treated LGG. The top 50 LGG mRNAs and proteins with altered expression are listed in Table  S5 (mRNAs) and Table S5 (proteins). Among the LGG genes affected by GELN-RNAs, the transcription repressor LexA was reduced due to GELN-RNA treatment at both the transcript and protein level ( Figures 2H, 2J, and S4I ). An alignment of nucleotide sequences using BLAST indicated that LGG LexA mRNA is one of the potential target genes of GELN gma-miR396e (Figures S1G and S4J) .
LGG treated with gma-miR396e had a lower level of LexA expression ( Figure 2L ) and grew faster than LGG treated with scrambled miRNA ( Figure 2M ).
GELN-RNAs Enhance LGG-Mediated Inhibition of Mouse
Colitis by Inducing the IL-22 Expression via Activation of the AHR Pathway RNA sequence analysis further revealed that GELN-RNAs harboring the complementary seed-matching sequence of LGG mRNA have the potential for binding gut bacterial mRNA (Table S1 , Figure S1G ). The evidence indicating a similarity in regulating the composition of gut microbiota of mice fed with GELNs and GELN-RNA ( Figure S5A , Table S6 ) prompted us to further examine whether GELN-RNAs could modulate bacterial function and in turn host biology. First, evidence showing PKH26-labeled GNVs encapsulating GELN-RNAs were present in LGG was visualized using confocal microscopy ( Figure 3A) .
LGG growth in MRS broth was induced by GELN-RNAs but not by scrambled RNAs ( Figure 3B ). The results indicated that mice fed GNV/GELN-RNAs had superior protection against DSS-induced mouse colitis compared with mice fed GNV/ scrambled RNA ( Figures 3C-3G ), suggesting that the protective effect on DSS-induced mouse colitis is GELN-RNA specific. The results generated from DSS-induced colitis in germ-free mice further demonstrated that LGG is required for better protection of mice against DSS-induced colitis because germ-free mice administered GNVs/GELN-RNAs without LGG did not experience a reduction in colitis severity ( Figures 3H-3J ).
Cytokine array analysis (Figures S6A-S6C) indicated that the levels of the majority of proinflammatory cytokines/chemokines were decreased in the colon tissue of germ-free mice treated with LGG + GNVs/GELN-RNAs (Figures S6B and S6C) in comparison with germ-free mice treated with LGG alone. In addition to confirmation of a reduction in the tumor necrosis factor alpha (TNF-a) level in pathogen-free (SPF) mice, ELISA analysis indicated that GELN-RNA treatment inhibited the induction of the proinflammatory cytokines IL-1b and TNF-a and promoted the production of IL-22 in colon mucus from DSS-treated SPF mice ( Figure 3K ). Failure of IL-22 induction by GELN-RNAs in germ-free mice suggested that IL-22 induction by GELN-RNAs was bacteria dependent. It is known that the AHR pathway contributes to induction of IL-22 (Monteleone et al., 2011) . We next tested whether the GELN-mediated inhibition of IL-1b and TNFa and the increase in IL-22 occurs through the AHR pathway. Knockout (KO) of AHR led to neither inhibition of IL-1b and TNF-a expression nor an increase in the expression of IL-22 in AHR KO mice with DSS-induced colitis ( Figure 3K ).
Next, we investigated the molecular basis of LGG + GNV/GELN-RNA-mediated induction of LGG metabolizes tryptophan to indole derivates, including I3A, which acts as a ligand for AHR, inducing local production of IL-22. High-performance liquid chromatography (HPLC) analysis indicated that the level of I3A in the feces of GELN-RNA-treated C57BL/6 mice dramatically increased ( Figure 4A ) compared with that in feces from mice treated with GELN-scrambled RNA, whereas the level of indole-3 acetamide (I3AM), another metabolite of tryptophan, decreased ( Figure 4B ). Interestingly, indole-3-acetaldehyde (IAAld), which is an intermediate metabolite product for synthesis of I3A, was also induced in the feces of GELN-RNA-treated mice ( Figure 4A ). We then determined the role of I3AM in the generation of I3A. HPLC analysis indicated that addition of I3AM to LGG cultures significantly inhibited GELN-RNA-mediated induction of the I3A precursor, IAAId ( Figures 4C-4E ). To further determine the inhibitory effect of I3AM on the production of LGG I3A, the quantity of IAAld ( Figure 4F , left panel) and I3A ( Figure 4F , right panel) in MRS medium of LGG treated with different concentrations of I3AM was analyzed. We found that I3AM inhibited the production of IAAld and I3A in a dose-dependent manner, and the inhibitory effect of I3AM on the production of I3A was canceled by additional IAAld ( Figure 4F ), suggesting that the I3AM-mediated inhibitory effect on I3A production occurs upstream of IAAId. Additional IAAId also canceled the I3AM-mediated inhibitory effort on IL-22 production ( Figure 4G , left panel). This inhibitory effect did not occur in AHR KO mice treated with LGG supernatant exposed to I3AM ( Figure 4G , right panel), indicating that the inhibitory effect of I3AM on LGG I3A-mediated induction of IL-22 occurs via the AHR pathway. Protein LC-MS/MS and mRNA sequencing analysis indicated that the expression of monooxygenase ycnE (embl-cds: CAR87039) in LGG ( Figure 5A ) was inhibited by GELN-RNAs (Figures 2J-2K ). Monooxygenase is a key enzyme that catalyzes tryptophan to I3AM (Kosuge et al., 1966; Stutz, 1958) . We found that GELN-derived mdo-miR7267-3p has a potential binding site for mRNA encoding LGG monooxygenase ycnE ( Figure 5B ). qPCR data generated from LGG treated with mdo-miR7267-3p indicated that ycnE gene expression was indeed inhibited ( Figure 5C ), and HPLC analysis indicated that mdo-miR7267-3p treatment leads to inhibition of I3AM and induction of I3A ( Figure 5D ). Tryptophan is metabolized into I3A and I3AM in LGG ( Figure 5E ). Production of I3AM and I3A is regulated by LGG ycnE. After chemical equilibrium is reached, the net amount of accumulated tryptophan is dependent on ycnE enzyme activity. Our data indicated that tryptophan was accumulated due to GELN-RNA-mediated blocking of I3AM production and was not utilized for I3A production at 100%.
To validate that the induction of I3A by GELN-RNAs is gut bacteria dependent, broad-spectrum antibiotic treatment was used to deplete gut bacteria prior to GELN-RNA administration. The I3A level in feces of antibiotic-treated mice was decreased, and GELN-RNAs no longer induced I3A until additional LGG was administered ( Figure 5F ). We next investigated whether the AHR pathway in gut lymphocytes of mice gavaged with GELN-RNAs is activated by evaluating phosphorylation of AHR and induction of IL-22. Mice were gavaged with GELN-RNAs 1 week prior to being treated with 2.5% DSS in drinking water for 1 additional week. Lymphoid cells were then isolated from the colon of treated mice. Western blotting analysis indicated that the levels of cytochrome P450 1A1 (CYP1A1) and phosphorylated AHR increased as a result of GELN-RNA treatment without affecting the total amount of AHR ( Figure 5G ). FACS analysis indicated that CD3 + RORgt + cells from GELN-RNAtreated mice exhibited increased IL-22 expression ( Figure 5H ). However, the induction of IL-22 in CD3 + RORgt + cells was abolished in AHR KO mice ( Figure 5H ). To further address whether the metabolites of LGG treated with GELN-RNAs have an impact on the induction of IL-22 via the AHR pathway, colon lymphocytes from naive B6 mice were incubated for 3 hr with I3A, MRS supernatant of LGG treated with GELN-RNAs, or GNVs only. ELISA results indicated that I3A induced expression of IL-22, and more IL-22 was induced when the colon lymphocytes were treated with LGG supernatant ( Figure 5I ). In contrast, there was no evidence of an impact of I3A and LGG supernatant on the induction of IL-22 in colon lymphocytes from AHR KO mice (Figure 5I) . Collectively, our data suggest that metabolites from the supernatants of LGG treated with GELN-RNAs induce IL-22 via the AHR pathway. Dysfunction of the gut epithelial barrier is a hallmark of inflammatory intestinal diseases. The intestinal epithelial barrier is maintained by tight junctions that connect adjacent epithelial cells and seal the paracellular space. IL-22 is critical for maintenance of the intestinal barrier function. We next tested whether GELN-RNA-mediated induction of IL-22 plays a causative role in protecting mice against colitis. Indeed, unlike wild-type mice, IL-22 KO led to a loss of GELN-RNA-mediated protection against DSS-induced colon injury (Figures 5J and 5K) . This result agreed with the fact that GELN-RNA reduced gut permeability, shown by a fluorescein-5-isothiocyanate (FITC)-conjugated dextran assay ( Figure S5B) , and increased the expression of Gjb, Cldn, and Jam2 genes, which play a role in regulating gut epithelial tight junction stability ( Figure S5C ). Collectively, these data suggest that the preventive effect of GELN-RNAs on mouse colitis is partially IL-22 dependent.
GELN ath-miR167a Prevents LGG Accumulation in Gut Mucosa by Downregulating the LGG Pili Gene, SpaC
LGG that took up GELN-RNAs exhibited reduced migration into the bloodstream and liver of DSS-treated SPF (Figures 6A and 6C) and germ-free ( Figure 6D ) mice compared with LGG alone. The mucosa-associated LGG was decreased, particularly in the colon ( Figure S5D ). These findings were corroborated with confocal microscopy ( Figures 6B and 6E) , showing that most of the PKH26-labeled LGG stayed in the intestinal lumen of mice that had been fed LGG prepulsed with GNVs/GELN-RNAs.
Moreover, the data generated from in vitro assays via colonyforming unit (cfu) quantification of LGG entry into C57BL/6 murine colon MC38 cells ( Figures 6F and 6H ) and human colon (A and B) The C57BL/6 mouse (n = 5) treatment schedule was the same as that described in Figure 3C . Representative HPLC analysis of (A) indole-3-carboxaldehyde (I3A) and indole-3-acetaldehyde (IAAld) via detection of UV absorbance at 300 nm, and (B) tryptophan and indole-3-acetamide (I3AM) using a fluorescence detector. Arrows point to the peak of the standard. *p < 0.05; **p < 0.01. (C and D) LGG grown in MRS medium with I3AM and GNV/scrambled RNAs or GNV/GELN-RNAs for 6 hr. HPLC analysis of IAAld and I3A in the MRS medium (C). The concentrations of the metabolites listed in the figure were quantified (D). *p < 0.05. (legend continued on next page) epithelial Caco2 cells ( Figures 6G and 6I ) and confocal examination of colocalization of LGG with GNVs/GELN-RNAs in MC38 cells ( Figure 6J ) further supported the notion that GELN-RNAs prevent LGG entry into both mouse and human gut epithelial cells.
The LGG pilus-specific protein SpaC was downregulated at both the transcriptional and protein levels when LGG was treated with GELNs ( Figures 2H and 2J) . Experimentally, based on array data ( Figures 2H and 2J ) and in vitro transmigration of colon epithelial cell data ( Figures 6F-6I) , we suggest that GELNRNAs prevent the invasion of LGG into gut epithelial cells. To further investigate the mechanism underlying how GELN-RNAs prevent LGG migration, nucleotide sequences were aligned using BLAST, and the results indicated that the GELN miRNA ath-miR167a might directly bind to the LGG pilus protein SpaC mRNA and regulate SpaC expression ( Figure S1G ). MC38 cells exposed to LGG treated with seven specifically selected GELN-derived miRNAs indicated that ath-miR167a-5p, athmiR842, and ath-miR827 can prevent the entry of LGG into gut epithelial cells ( Figures 7A and 7B ). Considering the critical role of SpaC in LGG migration and that ath-miR167a-5p has eight complementary bases with SpaC mRNA, we hypothesized that GELN ath-miR167a regulates the expression of SpaC in LGG ( Figure 7C) . Investigation of the effect of GELN miRNA on LGG migration in vivo indicated that ath-miR167a significantly reduced LGG translocation into the peripheral blood ( Figure 7D ), and LGG remained on mucosal surfaces ( Figure 7E ).
LGG treated with ath-miR167a had significantly downregulated SpaC mRNA ( Figure 7F ) and protein ( Figure 7G ) expression compared with LGG treated with a scrambled miRNA. Transmission electron microscopy (TEM) images showed that much less SpaC protein could be detected on pili of LGG treated with athmiR167a compared with those exposed to PBS or scrambled miRNA ( Figure 7H) . A mutation that disrupted the binding site for ath-miR167a entirely restored GFP expression ( Figure 7I ). To further determine whether SpaC is specifically targeted by miR167a-5p, we first analyzed the effects of SpaC on entry into gut epithelial cells and mucosa-associated LGG and miR167a-5p-treated LGG growth. Immuno-TEM demonstrated that SpaC-deleted (SpaC  del ) LGG had no detectable SpaC (Figure S7A) . SpaC del LGG was less efficient in entering MC38 cells than wild-type LGG ( Figure S7B ). Although the gene encoding for SpaC was not detected in SpaC del LGG ( Figure S7C , left panel)
and there was no difference in the in vitro growth between wild-type LGG and SpaC del LGG ( Figure S7C , middle panel), the in vivo results showed that the fewer SpaC del LGG were present on the mucosa than wild-type LGG ( Figure S7C , right panel). miR167a-5p treatment had no effect on the growth of SpaC del
LGG compared with scrambled miRNA ( Figure S7D ). Then, to further demonstrate the role of endogenous miR167a-5p in the context of GELN-RNA, we depleted miR167a-5p from the pooled GELN-RNAs with biotinylated anti-sense miR167a-5p. Then, GELN-RNA or scrambled miRNA was encapsulated in GNVs. qPCR data indicated that miR167a-5p was successfully depleted from the pooled GELN-RNA ( Figure S7E ). GELNRNAs with depletion of miR167a-5p had no effect on the expression of the LGG SpaC gene in comparison with GNV-scrambled miRNA-treated samples ( Figure S7F ). The depletion of GELN miR167a-5p had no effect on the level of mucosa-associated
LGG compared with data generated from GNV-scrambled miRNA-treated LGG ( Figure S7G ). Collectively, these data suggest that after exposure to GELN-RNA, the LGG SpaC gene is targeted and downregulated by GELN miR167a-5p.
DISCUSSION
Extensive research has shown that diet modulates the composition and function of the gut microbiota in humans and other mammals. Despite the body of knowledge that exists on fecal RNA, the impact of gut RNA on the microbiota is particularly poorly understood. Here, we identified small RNAs and miRNAs from ELNs and found that they modulate the composition of gut microbiota and their metabolites and inhibit mouse colitis. At a molecular level, our findings support the idea that (1) lipid-enriched ELNs send a signal that causes their uptake by gut bacteria; (2) ELN small RNAs mediate the cross-talk between gut microbiota and the host immune system, shaping the homeostatic balance between immunity and gut microbiota; and (3) ELN RNA regulates the composition, metabolites, growth, and localization of gut microbiota. Specifically, we found that gut probiotic LGG I3A induced by GELN-RNA promotes the expression of IL-22 through activation of the AHR signaling pathway, eliciting antimicrobial immunity and tissue repair at barrier surfaces. A given miRNA may have hundreds of different bacterial mRNA targets (Hausser and Zavolan, 2014) , several hundred miRNAs might be encapsulated in a given edible plant ELN, and ELNs from one type of edible plant could have a different miRNA profile than those from other plants. Therefore, it is conceivable that unlike endogenous miRNA released from host intestinal epithelial cells (Liu et al., 2016) , which release a limited number of miRNAs, a large number and variety of food-derived ELN miRNAs can be taken up by gut microbiota. In addition, in terms of gut bacterial targeting, the ELNs from one type of edible plant could also have a different lipid profile, resulting in a targeting signal that is distinct from other ELNs. Therefore, a large variety of ELN-derived miRNAs and lipids may meet the (F) Mice were treated with antibiotics in drinking water for 1 week followed by an oral gavage treatment, as indicated in the figure (n = 5). HPLC analysis of I3A in feces. requirement for potential regulation of the more than two million genes present in the gut microbiota through dietary-derived ELNs in a lipid targeting and a sequence-specific manner.
All organisms possess a diverse set of genetic programs that are used to alter cellular physiology in response to environmental cues. LexA acts as a transcriptional repressor of the SOS response genes coding primarily for error-prone DNA polymerases, DNA repair enzymes and cell division inhibitors (Miller et al., 2004) . Our finding that GELN gma-miR396e promotes LGG growth at least partly through inhibition of LexA expression opens up a paradigm for further study of whether ELNs from different types of food have a role in regulating LexA-mediated SOS activity in the intestinal microenvironment. In addition, since SOS activity has a direct effect on the bacterial cell cycle and survival in general and ELNs from different types of food have preferential bacterial hosts, it is conceivable that the SOS activity in different species of gut bacteria is dependent on what types of food are eaten. Therefore, our current study provides a foundation for further examination of whether ELN-dependent SOS activity has an effect on the composition of gut microbiota through regulating the bacterial cell cycle and bacteria survival.
Ingestion of probiotics, beneficial molecules or microbes, is designed to deliver a health benefit to the host by increasing the numbers of beneficial microbes or their products within the gut. From a therapeutic application aspect, using ginger ELN-derived liposomes, we were successful in orally delivering miRNA to target gut bacteria for treatment of mouse colitis. This strategy could provide an alternate approach for gene therapy in gut dysbiosisrelated disease and provide a rationale for ELN-based oral delivery of therapeutic miRNA for treatment of disease due to dysbiosis. It is conceivable that gut bacterial activity regulated by miRNA that interacts with bacterial mRNA in a gene-specific manner will have many advantages over other approaches such as chemotherapy drugs, which induce gut dysbiosis, and antibiotic treatment, which drives rapid development of resistant strains.
A variety of host-derived factors, such as antimicrobial peptides, play a crucial role in selecting and maintaining the stable diversity of the gut microbiota. Edible plant-derived factors that selectively regulate the stability of mucosa-associated microbiota have not been studied in detail. In this study, we found that the ratios of LGG among other species of mucosa-associated microbiota can remain stable, with a shift from mucosalassociated LGG to the majority of the LGG accumulating in the lumen. In zebrafish, an increased level of lumen-associated LGG has a more beneficial effect on gut barrier function than mucosal LGG (He et al., 2017) ; the role of lumen-associated LGG in mammals is less well understood. Our results explain how GELN small RNAs contribute to gut health via the LGG pilus-specific protein SpaC. Since all of the diets we have tested in the past contain ELN small RNAs, we propose the concept that spatial niche partitioning could be governed by diet ELN small RNAs, and this may help to explain both the long-term persistence of relatively stable numbers and the resilience of the microbiota, as well as the resistance to colonization by pathogens. Furthermore, the immune system has an active role in allowing only beneficial species to access these locations during homeostasis, as demonstrated in this study by IL-22. Our study opens up avenues for investigating whether other factors, such as GELN lipids and ELNs from other diets, may also participate in selection of which particular bacterial species are close to the epithelium and the creation of stable reservoirs for microorganisms to persist in the face of rapidly changing conditions in the gut lumen. Thus, through localized, immune-facilitated, and adherence-dependent ELN selection, the host can maintain the stability of a diverse community of microbial symbionts.
In conclusion, given the importance of gut microbiota in human physiology, our findings reveal an important molecular mechanism underlying how diet ELN miRNAs can cross talk with gut microbiota to maintain gut health. Because the composition of diet-derived ELN miRNAs and lipids is different among diets and each ELN miRNA has targets specific bacterial mRNA, this feature could be utilized for specific manipulation of the microbiome for human health and treatment of dysbiosis-related disease. However, the concept that food-derived ELNs are selectively taken up by the gut microbiome and host cells is relatively new in the field of gut physiology and health, and we are just beginning to define the individual steps in this process.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice Eight-to twelve-week-old male specific-pathogen-free (SPF) C57BL/6 mice and IL-22 knockout mice (C57BL/6-IL-22 tm1.1(icre)Stck /J) were purchased from the Jackson Laboratory (Bar Harbor, ME). AHR knockout mice were purchased from Taconic Biosciences. All mice were housed under specific-pathogen-free conditions. Germ-free mice were purchased from the National Gnotobiotic Rodent Resource Center (University of North Carolina, NC, Chapel Hill, NC) and maintained in flexible film isolators (Taconic Farm) at the Clean Mouse Facility of the University of Louisville. Animal care was performed following the Institute for Laboratory Animal Research (ILAR) guidelines, and all animal experiments were conducted in accordance with protocols approved by the University of Louisville Institutional Animal Care and Use Committee (Louisville, KY).
Human Subjects
The study involved 58 healthy volunteers between the ages of 25 and 46 years (30 males, 28 females) who were randomly assigned to a GELN group (14 males, 14 females) or a control group (16 males, 14 females) using simple randomization (Kim and Shin, 2014) (Kim and Shin, 2014) . The sample size for human subjects was determined by a one-way ANOVA-based power analysis (http://www. biostathandbook.com/power.html) (Given a power of 0.8, effect size of 0.4 and significance level of 0.05, the sample size needed (Festing and Altman, 2002) . The participants in the two groups were matched for age and sex. All clinical fecal samples from healthy volunteers were collected in the Department of Surgery, Huai'an First People's Hospital, Huai'an, Jiangsu, China with written informed consent from patients. Approval for the study was granted by the Institutional Research Ethics Committee at the Health Department of Huai'an. All subjects provided signed informed consent for participation in the study. Volunteers were recruited from the population in 2017 in Huai'an, Jiangsu, China. No subjects had a history of chronic gastrointestinal disease, antibiotic use within three months prior to testing, alcohol abuse, or smoking. To prevent bias in study results, participants were kept blinded to the allocation. Both researchers and participants were kept blinded to the treatment groups. Before taking GELNs, volunteers provided fecal samples at day 0. Participants drank GELNs in the amount of 200 mg in 10 ml of sterile 0.9% sodium chloride (GELNs group, n=28) or 10 ml of sterile 0.9% sodium chloride only (control group, n=30) every other day for 6 days. The feces of all enrolled subjects were collected at day 7.
Cells C57BL/6 murine colon adenocarcinoma MC-38 cells (sex is unknown, Kerafast) or human epithelial colorectal adenocarcinoma Caco-2 cells (male, American Type Culture Collection, ATCC) were grown in tissue culture plates with Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 U/mL penicillin, and 100 mg/mL streptomycin at 37 C in a 5% CO 2 atmosphere.
Bacteria
Lactobacillus rhamnosus (LGG, ATCC# 53103, Manassas, VA) was The SpaC-deleted LGG was cultured in Lysogeny broth (LB) (ISC BioExpress, Kaysville, UT) at 37 C. Ruminococcaceae sp. (ATCC, TSD-27) was grown in GS2 + cellobiose medium (Biddle et al., 2013) . Listeria monocytogenes (Listeria, ATCC# 15313) and Bacteroides fragilis (Fragilis, NCTC9343) were cultured in brain heart infusion (BHI) broth (Hardy Diagnostics, Santa Maria, CA) as described.
LGG was grown in MRS broth media at 37 C in anaerobic conditions for 14-16 h to an OD600 of 0.8-1.0. Bacterial viability and concentration were checked by MRS agar platting. Cultures were centrifuged and the bacterial pellet was diluted in MRS for in vitro experiments and in PBS for gavaging at 10 9 CFU/mouse per day.
METHOD DETAILS Preparation of Plant ELNs
To prepare plant exosome-like nanoparticles (ELNs), peeled Hawaiian ginger roots (Simply ginger, PLU#:4612), carrot, garlic, turmeric roots and grapefruit were used for isolation and purification of ELNs using a previously described method (Mu et al., 2014) . Briefly, the plants listed above were peeled and then homogenized in a high-speed blender for 1 min. The juice was collected after net filtration. The supernatant was collected after centrifugation at 1,000x g for 10 min, 2,000x g for 20 min, 4,000x g for 30 min, and 10,000x g for 1 h. The pellets containing nanoparticles derived from each plant were spun down at 100,000x g for 1.5 h at 4 C. The isolated exosomes were further purified in a sucrose gradient (8, 30, 45 , and 60% sucrose in 20 mM Tri-Cl, pH 7.2), followed by centrifugation at 100,000x g for 1.5 h at 4 C. Purified GELNs were fixed in 2% paraformaldehyde and imaged under a Zeiss EM 900 electron microscope using a previously described method (Mu et al., 2014) .
The purity of GELNs was evaluated by calculating the ratio of particle to protein (Webber and Clayton, 2013) . The size distribution of GELNs was analyzed using a Zetasizer Nano ZS (Malvern Instrument, UK) at a flow rate of 0.03 ml per min. The protein concentration of GELNs was determined using a BioRad Protein Quantitation Assay kit with bovine serum albumin as the standard.
RNA Extraction
Total RNA containing miRNA was isolated from ELNs and murine tissue using a miRNeasy mini kit (Qiagen) according to the manufacturer's instructions. In brief, 50 mg of plant-derived ELNs or tissue was disrupted in QIAzol Lysis Reagent. Tissue was homogenized using a tissue grinder before disruption. The homogenate was mixed with 140 ml of chloroform and centrifuged. The upper aqueous phase was mixed with 1.5 volumes of ethanol and loaded into an RNeasy spin column. The flow-through was discarded after centrifugation, and the column was washed with RWT and RPE sequentially. Total RNA was eluted with RNase-free water. Bacterial mRNA was isolated using RiboPure Bacteria and MICROBExpress kits (Thermo Fisher Scientific) according to the manufacturers' instructions. The quality and quantity of the isolated RNA were analyzed using a NanoDrop spectrophotometer and Agilent Bioanalyzer.
Preparation of Plant Nanovectors
To prepare GELN nanovectors (GNVs) and grapefruit ELN nanovectors (GFNVs), the GELN or grapefruit ELN-derived lipids were extracted with chloroform and dried under vacuum. To generate GNVs and GFNVs, 200 nmol of lipid was suspended in 200-400 ml of 155 mM NaCl with or without 10 mg of ELN-derived RNA. After UV irradiation at 500 mJ/cm 2 in a Spectrolinker crosslinker (Spectronic Corp.) and a bath sonication (FS60 bath sonicator, Fisher Scientific) for 30 min, the pelleted particles were collected by centrifugation at 100,000x g for 1 h at 4 C,. The RNA encapsulation efficiency of GNVs (68 ± 5%) was determined using a previously described method (Teng et al., 2016) .
Plant ELN Distribution In Vivo
Plant ELNs labeled with DiR dye were administered to C57BL/6 mice (n=5) by oral gavage at 500 mg/kg. The labeled plant ELNs in the gut of mice were visualized using an Odyssey CLx Imaging System (Licor Biosciences).
Migration Assays MC-38 or Caco-2 cells (ATCC) were seeded at 1x10 5 cells per well in a 12-well tissue culture plate with Dulbecco's modified Eagle's medium (DMEM) without antibiotics. The cells were inoculated with 1 3 10 7 bacteria per well for 90 minutes at 37 C in a 5% CO 2 atmosphere to allow bacterial adhesion and entry. The number of intracellular bacteria was quantified using a previously described method (Zhang and Wang, 1998) .
DSS Colitis Model
Colitis was induced by addition of dextran sulfate sodium (DSS, MP Biomedicals, Santa Ana, CA) to autoclaved drinking water at 2.5%. Colitis development was monitored daily by assessing body weight and presence of blood in the stool.
Bacterial Translocation
Bacterial translocation from the murine gut to peripheral blood and liver was determined at the indicated times presented in the relevant figures after oral bacterial administration. Fifty microliters of anticoagulant blood were cultured on MRS agar for 48 h at 37 C in an anaerobic chamber. Liver tissue samples were homogenized in 0.5% Triton X-100/PBS, and 100 ml of the homogenates were cultured on MRS agar plates. After 48 h of incubation, CFUs were counted, and the results are expressed as number of bacteria detected/mL of blood or gram of liver.
Labeling of Bacteria and Nanoparticles Bacteria, ELNs or ELN nanovectors were labeled with PKH26 or PKH67 Fluorescent Cell Linker Kits (Sigma) in accordance with the manufacturer's instructions. After a wash with PBS, bacteria pellets, ELNs or ELN nanovectors were suspended in 250-500 ml of diluent C with 2-4 ml of PKH26/67 and subsequently incubated for 30 min at room temperature. After centrifugation for 5 minutes at 13,000x g, labeled LGG, ELNs or ELN nanovectors were resuspended for further experiments.
Bacteria GELN Uptake Assay Briefly, 1x10 7 LGG cells were incubated for 30 min at room temperature with 1 mg of PKH26-labeled GELNs or 1 mg of GELN RNA encapsulated in GNVs. After two washes with PBS, LGG uptake of GELNs was visualized using a confocal microscope. To exclude the possibility of detecting GELNs remaining (adhering) on the outside of bacteria, the bacteria were washed three times with medium and treated with 100 ml of 0.5% Triton X-100 for eight minutes, followed by the immediate addition of bacteria broth to wash bacteria 2x before the bacteria were imaged using confocal microscopy. (Note: 0.5% Triton X-100 did not affect bacterial viability for at least 30 minutes after addition).
Immunogold Labeling of LGG Pili and TEM To visualize LGG pili via transmission electron microscopy (TEM), LGG cultures were grown overnight (OD 600 <1.0) and washed once with PBS. Formvar-carbon-coated copper grids (Electron Microscopy Sciences, PA) first were floated for 1 h on droplets of the diluted LGG at 10 7 /mL in PBS, washed several times with 0.02 M glycine in PBS, and then treated with a blocking solution of 1% bovine serum albumin (BSA) in PBS. The grids were then floated for 1 h on droplets of anti-SpaC serum (1:100) in blocking solution. After a wash with 0.1% BSA in PBS, the grids were incubated for 20 min with protein A-conjugated 10-nm-diameter gold particles (Cytodiagnostics, Canada) diluted 1:55 in blocking solution. After one wash in PBS, the grids were fixed with 1% glutaraldehyde, washed with distilled water, and then stained with 1% ammonium molybdate on the surface of the EM grid. After excess ammonium molybdate was removed from the grid, images were visualized using a Thermo-Fisher TEM Tecnai Spirit at 80 kV, and images were collected with an AMT XR60 digital camera.
Quantitative Real-Time PCR for RNA Expression The quantity of mature miRNAs was determined with quantitative real-time PCR (qPCR) using a miScript II RT kit (Qiagen) and miScript SYBR Green PCR Kit (Qiagen) with Qiagen 3' universal primers. The 5' specific miRNA primers used are listed in Table S7 . For analysis of gene mRNA expression, 1 mg of total RNA was reverse transcribed using SuperScript III reverse transcriptase (Invitrogen), and quantitation was performed using SsoAdvancedTM Universal SYBR Green Supermix (BioRad) and the listed primers (Table S7) with SsoAdvancedTM Universal SYBR Green Supermix (BioRad). qPCR was performed using a BioRad CFX96 qPCR System with each reaction run in triplicate. Analysis and fold-changes were determined using the comparative threshold cycle (Ct) method. Changes in miRNA or mRNA expression was calculated as fold-change.
Quantification of Gut Bacteria Using QPCR For gut bacteria identification, qPCR was performed from gut microbiota-derived DNA extracted with a QIAamp DNA Stool Mini Kit (Qiagen). All kits were used according to the manufacturer's instructions. Quantitation was performed using SsoAdvancedTM Universal SYBR Green Supermix (BioRad), and the bacterial specific primers are listed in Table S7 . qPCR was performed using the BioRad CFX96 qPCR System with each reaction run in triplicate. Analysis and fold-change were determined using the comparative threshold cycle (Ct) method.
Plasmid Construction and Mutagenesis
The SpaC fragment (339-800, LGG_RS02140) spanning the sequences of the potential target (710-717) of GELN ath-miR167a was obtained by PCR with cDNA from LGG RNA. PCR was performed using a BioRad thermal cycler T100. The 462-bp PCR product amplified by the primer pair SpaC-pGFPuv-F: GCGCATGCCTGCAACTAATTTTGTCGCAAACG and SpaC-pGFPuv-R: CCTCTA GAACAGTTTTCAGCAGGCATCC was ligated into the SphI and XbaI restriction enzyme sites of a pGFPuv vector (Clontech) to obtain a green fluorescent protein (GFP) expression reporter. SpaC-pGFPuv fused with the SpaC gene fragment, which can be expressed in prokaryotic cells. To generate mutants of SpaC, the oligonucleotide primers SpaCMut-F, CTGTAGGTGCTGTAACTGCCTGAA TACCGTAATAC, and SpaCMut-R, GTATTACGGT ATTCAGGCAG TTACAGCACC TACAG, were designed to specifically disrupt the putative ath-miR167a binding site. A GeneartÒ Site-Directed Mutagenesis System (#A13282, Invitrogen) was used in conjunction with specific primers to introduce a SpaC mutation in the pGFPuv construct according to the manufacturer's instructions. After mutant strand synthesis (using T4 DNA polymerase) and ligation, the resultant plasmids were introduced into E. coli, and transformants were selected using ampicillin resistance. Further restriction endonuclease SphI and XbaI analysis was performed to screen clones, and all of the constructs were confirmed by DNA sequencing.
Microbiota 16S rRNA Gene Sequencing
GELNs were administered by gavage to C57BL/6 mice (500 mg/kg of body weight) three times in seven days (n=5). To identify bacterial strains that preferentially take up GELNs, PKH26-labeled GELNs were administered by gavage, and PKH26-positive microbiota from fecal samples were sorted using a BD FACSAriaÔ III cell sorter (BD Biosciences, San Jose, CA). Bacterial DNA from fecal samples was isolated with QIAamp DNA Stool Mini Kits (Qiagen), and bacterial strains were investigated using 16S rRNA gene sequencing. DNA (15 ng) was used as a template to amplify the 16S rRNA gene using a High Fidelity PCR system kit (Roche). The v1-v3 regions of 16S ribosomal RNA gene were amplified using 27f (AGAGTTTGATCCTGGCTCAG) and 534r (ATT ACCGCGGCTGCTGG) primers (1 mM). The primers were anchored with adaptor (adopter A: 5' CCATCTCATCCCTGCGTGTCTCC GACTCAG 3' and adopter B: 5' CCTATCCCCTGTGTGCCTTGGCAGTCTCAG 3') and Multiplex Identifiers (MIDs; 10 bp long). The multiplexed amplicons were purified using a QIAquick Gel Extraction Kit (Qiagen). The amplicon sequence was conducted using the 454 Jr. Sequencing platform. The 16S rRNA gene sequences were analyzed using QIIME platform scripts (www.qiime.org). The microbial classification was performed with the GreenGenes reference data base (gg_otus-13_8) using QIIME tools (Caporaso et al., 2010) . By applying hierarchical clustering algorithms (HCAs), we determined the species clustering based on the operational taxonomic unit (OTU) using amplicon sequencing of 16S RNA. The reference sequences allowed sorting of the results into OTUs by clustering 97% sequence similarity (uclust) and classification according to various taxonomic ranks (phylum, order, class, family, genus, and species). The percentage of each bacterial species was virtualized with Interactive Tree Of Life (iTOL) and R software (Letunic and Bork, 2007) .
Mouse Cytokine Array
To investigate effects of GELN RNAs on the regulation of cytokine expression in colon epithelia, germ-free mice with DSS-induced colitis were administered 10 9 LGG pretreated with GNVs or GNVs with GELN RNAs. The colon tissue extracts were prepared in modified radioimmunoprecipitation assay (RIPA) buffer (Sigma) with the addition of protease and phosphatase inhibitors (Roche). Cytokine proteins were analyzed with a Proteome Profiler Mouse XL Cytokine Array Kit (R&D Systems, ARY028). Quantification of the spot intensity in the arrays was conducted with background subtraction using ImageJ.
Proteomic LGG Sample Preparation
Briefly, 1x10 7 LGG were incubated with 1 mg GELNs for 2 h and then harvested by centrifugation at 13,000x g for 5 min. Bacteria were suspended in lysis buffer (2% SDS, 100 mM DTT, 20 mM Tris-HCl pH 8.8) for 20 min at 95 C.
LGG lysate was collected from supernatants after centrifugation, and concentrations were estimated using an RC DC Protein Assay Kit (BioRad, Hercules, CA). Protein aliquots (50 mg) were diluted into 4% SDS / 0.1 M Tris-HCl pH 8.5 and 1 M DTT and processed according to the filter-aided sample preparation (FASP) method as described previously . The digested, ultrafiltered samples were trap-cleaned with C18 PROTOTM, 300 Å Ultra MicroSpin columns; lyophilized by vacuum centrifugation; and redissolved in 16 ml of 2% v/v acetonitrile. Concentrations were estimated based on absorption at 205 nm using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, San Jose, CA, USA).
LC-MS Analysis of LGG Protein
Liquid chromatography-mass spectrometry (LC-MS) was carried out using a method described previously . Proteome Discoverer v1.4.1.114 (Thermo) was used to analyze the data collected by MS. The database used in Mascot v2.5.1 and SequestHT searches was the 2/17/2017 version of the LGG proteome from UniprotKB (Proteome ID UP000000955). Scaffold was used to calculate the false discovery rate using the Peptide and Protein Prophet algorithms. Proteins were grouped to satisfy the parsimony principle. The proteins were clustered based on differential expression, and heat maps representing differentially regulated proteins by GELNs were generated using R software. calculated for each miRNA-mRNA pair to estimate the likelihood of having a functional pair. Once all p-values were calculated, the false discovery rate (FDR) was obtained using the Benjamini-Hochberg method (Benjamini and Hochberg, 1995) for multiple P-value correction.
Microbial DNA QPCR Arrays To determine whether ELN RNA has an effect on the composition of major gut microbial species, mice were gavaged with GELN RNAs and grapefruit and carrot ELN RNAs encapsulated in the GELN lipid-derived liposomes (GNVs) (500 mg/kg mouse weight in 100 ml PBS; n=5). The GNVs were given to mice once every other day for seven days. Three hours after the last dose, the mice were sacrificed, fecal DNA was extracted, and a qPCR array was performed using Qiagen Custom Microbial DNA qPCR Arrays (cat# 330161) on an Applied Biosystems ViiAÔ 7 Real-Time PCR System. Normalization to Pan Bacteria (BPCL00362A) was performed using a threshold cycle (Ct) to correct for potential DNA input or RT efficiency biases. DNA qPCR array data generated from the fecal samples were analyzed using SPSS 16.0 software and are based on fold-changes compared with PBS as a control. Heat maps generated from qPCR data using software R reflect the abundance of the microbial species analyzed.
Thin-Layer Chromatography (TLC) Analysis
Lipids from ELNs were extracted and quantitatively analyzed using a method previously described (Wang et al., 2013) . TLC was performed (Zhuang et al., 2015) . Briefly, HPTLC-plates (silica gel 60 with a concentrating zone, 20 cm 3 10 cm; Merck) were used for the separation. After aliquots of concentrated lipid samples were extracted from plant ELNs, they were separated on a plate that had been developed with chloroform/methanol/acetic acid (190:9:1, by vol). After drying in air, the plates were sprayed with a 10% copper sulfate and 8% phosphoric acid solution and then charred by heating at 180 C for 5 min. The bands of lipid on the plate were imaged using an Odyssey Scanner (Licor Bioscience, Lincoln NE).
Lipidomic Analysis with Mass Spectrometry
Lipid samples extracted from ELNs were submitted to the Lipidomics Research Center, Kansas State University (Manhattan, KS) for analysis using a method previously described. In brief, the lipid composition was determined using triple quadrupole MS (Applied Biosystems Q-TRAP, Applied Biosystems, Foster City, CA). The protocol has been previously described (Wang et al., 2013) . The data are reported as the concentration (nmol/mg ELNs) and percentage of each lipid within the total signal for the molecular species determined after normalization of the signals to internal standards of the same lipid class.
Histological Analysis
For hematoxylin and eosin (H&E) staining, tissues were fixed with buffered 10% formalin solution (SF93-20; Fisher Scientific, Fair Lawn, NJ) overnight at 4 C. Dehydration was achieved by sequential immersion in a graded ethanol series of 70%, 80%, 95%, and 100% ethanol for 40 min each. Tissues were embedded in paraffin and subsequently cut into ultrathin slices (5 mm) using a microtome. Tissue sections were deparaffinized in xylene (Fisher), rehydrated in decreasing concentrations of ethanol in PBS, and stained with H&E, and the slides were scanned with an Aperio ScanScope. For frozen sections, tissues were fixed with periodate-lysine-paraformaldehyde (PLP) and dehydrated with 30% sucrose in PBS overnight at 4 C, and nuclei were stained with 4',6-diamidino-2-phenylindole dihydrochloride (DAPI). The slides were scanned using an Aperio ScanScope or visualized via confocal laser scanning microscopy (Nikon, Melville, NY) as previously described .
HPLC Analysis of Tryptophan Metabolites
The fecal samples and LGG MRS broth were diluted with an equal volume of methanol. After centrifugation at 10,000x g for 30 min, 50 ml of supernatant was injected for high-performance liquid chromatography (HPLC) analysis. The HPLC analysis was performed on an Agilent 1260 Infinity system equipped with an Agilent ZORBAX SB-C18 column (4.6 x 150 mm, 3.5 mm), with following parameters: mobile phase A: 5 mM NH 4 Ac in water modified with 0.1% formic acid (v/v); mobile phase B: 5 mM NH 4 Ac in 90% acetonitrile modified with 0.1% formic acid (v/v); gradient: 5% B in first 5 min, 5-20% B for 10 min, hold 20% B for 5 min, 20%-50% B for 5 min, hold 50% B for 5 min, 50%-100% B for 5 min, hold 100% B for 10 min, 100-5% B for 5 min; flow rate: 1.0 ml/min; temperature: 30 C. UV detection at 300 nm was used to monitor indole-3-carboxaldehyde (I3A) and indole-3-acetaldehyde (IAAld); FLD (ex=280 nm, em=350 nm) was used for detection of tryptophan and indole-3-acetamide (I3AM). The standard for I3A (cat#: 129445-5g), I3AM (cat#: 286281-1G), IAAld (cat#: I1000-25MG) and tryptophan (Cat: T0254-25g) were purchased from Sigma.
Enzyme-Linked Immunosorbent Assay (ELISA)
The cytokine IL-22, IL-1b and TNFa levels in cell culture supernatants or mouse colon mucus were quantified using ELISA kits (eBioscience) according to the manufacturer's instructions. Briefly, a microtiter plate was coated with anti-mouse IL-22, IL-1b and TNFa antibody at 1:200 overnight at 4 C. Excess binding sites were blocked with 200 ml of 1x ELISA/ELISPoT Diluent (eBioscience) for 1 h at 22 C. After washing three times with PBS containing 0.05% Tween 20, the plate was incubated with detection antibody in blocking buffer for 1 h at 22 C. After three washes, avidin conjugated with horseradish peroxidase and substrate were each added sequentially for 1 h and 30 min at 22
C. An analysis of absorbance at 405 nm using a microtiter plate reader (BioTek Synergy HT) followed.
